HAMPTON, N.J. (AP) _ Celldex Therapeutics Inc. (CLDX) on Thursday reported a loss of $23.1 million in its first quarter.The Hampton, New Jersey-based company said it had a loss of 49 cents per share.The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 46 cents per share.The biopharmaceutical company posted revenue of $174,000 in the period._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CLDX at https://www.zacks.com/ap/CLDX